At the 2021 Annual General Meeting of Probi AB, the Probi Nomination Committee ahead of the Annual General Meeting 2022 was appointed. The Fourth Swedish National Pension Fund has informed that Marianne Flink will replace Jannis Kitsakis as a member of the Nomination Committee, representing the Fourth Swedish National Pension Fund.
The Nomination Committee ahead of the Annual General Meeting 2022 will henceforth consist of Heinz-Jürgen Bertram (representing Symrise), Monica Åsmyr (representing Swedbank Robur funds), Marianne Flink (representing the Fourth Swedish National Pension Fund) and Bengt Jeppsson (representing minor shareholders).
For further information, please contact:
Henrik Lundkvist, CFO, Probi, Phone +46 46 286 89 41, E-mail: firstname.lastname@example.org
Probi[®] is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. The company is an expert in managing stable, live bacteria from research through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 717 m in 2020. Probi's shares are listed on Nasdaq Stockholm, Mid-cap. and there were around 4,000 shareholders on December 31, 2020.
This information was distributed by Cision http://www.cisionwire.se/